Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Lancet
; 395(10234): 1423-1433, 2020 05 02.
Article
in En
| MEDLINE
| ID: mdl-32197105
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccination
/
Dengue
/
Dengue Virus
/
Dengue Vaccines
Type of study:
Clinical_trials
/
Guideline
Limits:
Adolescent
/
Child
/
Child, preschool
/
Humans
Country/Region as subject:
America central
/
America do sul
/
Asia
/
Brasil
/
Colombia
/
Nicaragua
/
Panama
/
Republica dominicana
Language:
En
Journal:
Lancet
Year:
2020
Document type:
Article
Country of publication: